GENE ONLINE|News &
Opinion
Blog

Lung Cancer
Roche’s Tecentriq Bags Landmark FDA Approval as First-Line Monotherapy for Metastatic NSCLC
2020-05-20
CRISPR-Edited T cells Evaluated in Combating Lung Cancer
2020-05-10
R&D
AACR 2020 Conference – Advances in the Field of Lung Cancer Targeted Therapies
2020-04-28
The Evolution of Lung Cancer Therapies at a Glance
2020-04-16
Overwhelming Efficacy Allows AstraZeneca to End Cancer Drug Trial Sooner
2020-04-12
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
Vizimpro bags EU approval for NSCLC treatment
2019-04-16
Weekly Top 5 in China (0210-0216)
2019-02-18
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Pembrolizumab Upstages Topline PD-1/L1 drugs in lung cancer tussle
2018-11-06
R&D
A new player emerges in the non-small cell lung cancer (NSCLC) therapy scene
2018-10-11
Fighting Lung Cancer with Precision Warfare
2018-06-21
1 2 3
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
EVENT
Scroll to Top